A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
about
A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study to Compare Pertuzumab ...... itive Metastatic Breast Cancer
@en
type
label
A Study to Compare Pertuzumab ...... itive Metastatic Breast Cancer
@en
prefLabel
A Study to Compare Pertuzumab ...... itive Metastatic Breast Cancer
@en
P4844
P1476
Phase III Study to Compare Tra ...... ositive Advanced Breast Cancer
@en
P1813
ATTILA
@en
P3098
NCT03811418
P580
2019-03-01T00:00:00Z
P582
2023-12-31T00:00:00Z